Parmax Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 inter alia to consider and approve Unaudited financial results for the quarter ended on 30th June 2024 and to discuss any other matter with the permission of the board.